|
[1]
|
Wu ZY, Chen JF, Scott SR, McGoogan JM. History of the HIV epidemic in China. Curr HIV/AIDS Rep 2019;16(6):458 − 66. http://dx.doi.org/10.1007/s11904-019-00471-4CrossRef
|
|
[2]
|
Chinese Centers for Disease Control and Prevention. National epidemiological profile of statutory infectious diseases in 2020. 2021. http://www.nhc.gov.cn/jkj/s3578/202103/f1a448b7df7d4760976fea6d55834966.shtml. [2023-8-13]. (In Chinese). http://www.nhc.gov.cn/jkj/s3578/202103/f1a448b7df7d4760976fea6d55834966.shtml |
|
[3]
|
Erlandson KM, Karris MY. HIV and aging: reconsidering the approach to management of comorbidities. Infect Dis Clin North Am 2019;33(3):769 − 86. http://dx.doi.org/10.1016/j.idc.2019.04.005CrossRef
|
|
[4]
|
Han MJ. Analysis of the epidemic situation and prevention prospects of AIDS in China. Chin J AIDS STD 2023;29(3):247 − 50. http://dx.doi.org/10.13419/j.cnki.aids.2023.03.01 (In Chinese). CrossRef
|
|
[5]
|
Ma Y, Dou ZH, Guo W, Mao YR, Zhang FJ, McGoogan JM, et al. The human immunodeficiency virus care continuum in China: 1985-2015. Clin Infect Dis 2018;66(6):833 − 9. http://dx.doi.org/10.1093/cid/cix911CrossRef
|
|
[6]
|
Zhang FJ, Dou ZH, Ma Y, Zhang Y, Zhao Y, Zhao DC, et al. Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort study. Lancet Infect Dis 2011;11(7):516 − 24. http://dx.doi.org/10.1016/S1473-3099(11)70097-4CrossRef
|